Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Emergency Surgery
  •  Urology
  •  Bariatric Surgery
  •  Gynecological Surgery
  •  Orthopaedic Surgery
  •  Cardiovascular Surgery
  •  Surgical Oncology
  •  Otolaryngology - Head and Neck Surgery


Citation: Clin Surg. 2023;8(1):3670.Research Article | Open Access

Isolated Limb Perfusion – A Single Center Experience

Srđan N, Igor D, Milan K, Vladimir J, Luka P, Nikola V, Stefan G, Ognjen P and Lila R

Department of Surgical Oncology, Institute for Oncology and Radiology of Serbia, Serbia

*Correspondance to: Srdjan Nikolic 

 PDF  Full Text DOI: 10.25107/2474-1647.3670


Introduction: Isolated limb perfusion is a method of locoregional treatment of tumors in the upper and lower extremities with high doses of chemotherapeutic agents that are delivered to the tumor in conditions of hyperthermia with the intention to keep the maximum drug concentration in the tumor and minimize systemic effects. Aim: The aim of our study was to analyze the initial results and responses of patients to isolated limb perfusion as a surgical intervention and to show the justification of performing this procedure in carefully selected patients. Material and Methods: This retrospective study was conducted at the Clinic for Surgical Oncology of the Institute for Oncology and Radiology of Serbia. The study included 42 patients who underwent isolated limb perfusion procedure with the cytostatic melphalan in the period from 2015 to 2021. Results: The number of females included in the study was 27 (64.3%) and the number of males 15 (35.7%). The average age of patients was 57 (16-77) years. Isolated perfusion of the lower extremity was performed in 35 (83.3%) patients, while the upper extremity was treated in 7 (16.7%) patients. The total number of patients who had a good response to the procedure was 27 (69.2%), while 12 (30.8%) did not respond to isolated perfusion. 70.6% of patients with advanced and/or recurrent melanoma and 61.1% of patients with advanced soft tissue sarcoma had a positive treatment outcome. Patients with aggressive fibromatosis responded well in 100% of cases. Conclusion: Isolated limb perfusion is an effective therapeutic option for well-selected patients with locoregional advanced disease. This procedure can successfully treat both locally advanced and recurrent melanomas and soft tissue sarcomas, as well as patients with aggressive fibromatosis.


Isolated limb perfusion; Melanoma; Soft tissue sarcomas; Aggressive fibromatosis

Cite the article

Srđan N, Igor D, Milan K, Vladimir J, Luka P, Nikola V, et al. Isolated Limb Perfusion – A Single Center Experience. Clin Surg. 2023; 8: 3670..

Search Our Journal

Journal Indexed In

Articles in PubMed

Risk Factors for Visual Impairment in an Uninsured Population and the Impact of the Affordable Care Act
 PubMed  PMC  PDF  Full Text
Sildenafil Transiently Delays Early Alveolar Bone Healing of Tooth Extraction Sockets
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

PROZ is a Biomarker for Progression of Early Hepatocellular Carcinoma and Correlated with Tumor- Infiltrating Immune Cells
 Abstract  PDF  Full Text
Optimal Surgical Procedure for Ovarian Metastases from Colorectal Cancer based on a Retrospective Analysis
 Abstract  PDF  Full Text
View More...